Roxi-AI
Roxi-AI aims to enhance biopharmaceutical dealmaking by providing objective risk assessment, benchmarking, and mitigation. Their proprietary platform leverages data, analytics, and AI to evaluate assets across six critical areas, integrating diverse data sets and applying advanced analytics to improve decision-making. The company offers solutions like ROXI 100 for risk evaluation, ROXI INDEX for asset grading, BENCHMARK PRO for industry comparisons, SIMULATOR for commercial success likelihood, and ROXI CONNECT, a deal marketplace. Roxi-AI also provides services in innovation acceleration, real-world data strategy, R&D strategy, medical affairs, and launch & commercialization, all designed to streamline asset evaluation and drive success in the biopharma industry.
Roxi-AI
Roxi-AI aims to enhance biopharmaceutical dealmaking by providing objective risk assessment, benchmarking, and mitigation. Their proprietary platform leverages data, analytics, and AI to evaluate assets across six critical areas, integrating diverse data sets and applying advanced analytics to improve decision-making. The company offers solutions like ROXI 100 for risk evaluation, ROXI INDEX for asset grading, BENCHMARK PRO for industry comparisons, SIMULATOR for commercial success likelihood, and ROXI CONNECT, a deal marketplace. Roxi-AI also provides services in innovation acceleration, real-world data strategy, R&D strategy, medical affairs, and launch & commercialization, all designed to streamline asset evaluation and drive success in the biopharma industry.